In the early morning of November 26, JD health released its global offering documents, which will issue 381.9 million shares through Hong Kong IPO, of which 95% are international placements and 5% are public offerings. The offering price is HK $70.58 per share. The Hong Kong public offering of 19095000 shares, code 6618, includes Haitong Securities, UBS and BofA Merrill Lynch. < p > < p > the IPO of JD Health received six cornerstone investors who agreed to subscribe for up to US $1.35 billion in shares, including Singapore’s sovereign wealth funds GIC, tiger global, Hillhead capital and BlackRock. The proceeds will be used for business expansion, research and development, potential investments and acquisitions, and general corporate purposes. < / P > < p > Jingdong health has been operating independently since February 2014, launched online consultation service in December 2017, officially registered and established the company in 2018, completed a round of $900 million financing in November 2019, and completed a round of $900 million financing in August 2020. As of June 30, 2020, more than 150 million users have used JD health’s platform to purchase medicine and health products or medical and health services. < / P > < p > from 2017 to 2019, the total income of JD health was 5.6 billion yuan, 8.2 billion yuan and 10.8 billion yuan respectively, and in the first half of 2020, it was 10.8 billion yuan. Excluding the changes in fair value and non recurring profit and loss, the net profit of JD health from 2017 to 2019 was 210 million yuan, 250 million yuan and 340 million yuan, and 370 million yuan in the first half of 2020. Global Tech